Polaris Group (TPE:6550) OCF Margin %: -9,842.52% (As of Dec. 2025)


TPE:6550 Polaris Group TPE:6550
59 GF Score
Price NT$12.50
GF Value NT$55.10
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Polaris Group OCF Margin %?

Polaris Group TPE:6550 -4.21% 59 OCF Margin % is -9,842.52% as of Dec. 2025. GuruFocus rates TPE:6550 with a GF Score™ of 59/100 and a GF Value™ of NT$55.10 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 959 Biotechnology companies, Polaris Group ranks worse than 92.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Polaris Group's Cash Flow from Operations for the three months ended in Dec. 2025 was NT$-592.32 Mil. Polaris Group's Revenue for the three months ended in Dec. 2025 was NT$6.02 Mil. Therefore, Polaris Group's OCF Margin % for the quarter that ended in Dec. 2025 was -9,842.52%.

As of today, Polaris Group's current OCF Yield % is -19.60%.

The historical rank and industry rank for Polaris Group's OCF Margin % or its related term are showing as below:

TPE:6550' s OCF Margin % Range Over the Past 10 Years
Min: -16781.79   Med: -6061.13   Max: -1893.21
Current: -5896.98

During the past 12 years, the highest OCF Margin % of Polaris Group was -1893.21%. The lowest was -16781.79%. And the median was -6061.13%.

TPE:6550's OCF Margin % is ranked worse than
92.18% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs TPE:6550: -5896.98

Polaris Group OCF Margin % Related Terms

Polaris Group OCF Margin % Historical Data

* Premium members only.

The historical data trend for Polaris Group's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polaris Group OCF Margin % Chart

Polaris Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,585.25 -15,981.94 -16,781.79 -1,893.21 -5,896.98

Polaris Group Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,710.16 -7,266.97 -7,049.95 -3,362.55 -9,842.52

TPE:6550 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Polaris Group's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polaris Group OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Polaris Group's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Polaris Group's OCF Margin % falls into.


TPE:6550
59GF Score
Polaris Group TPE:6550
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Polaris Group OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Polaris Group's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-2394.291/40.602
=-5,896.98 %

Polaris Group's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-592.323/6.018
=-9,842.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -9,842.52% mean?
Polaris Group (TPE:6550) has a OCF Margin % of -9,842.52% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Polaris Group and its competitors. According to the industry distribution chart, Polaris Group ranks #884 out of 959 companies in the Biotechnology industry, placing it in the top 92.2%.
Is Polaris Group's OCF Margin % too high?
Polaris Group's current OCF Margin % is -9,842.52%. Based on the distribution chart, Polaris Group ranks #884 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Polaris Group has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polaris Group's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Polaris Group ranks #884 out of 959 companies for OCF Margin %. This places Polaris Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Polaris Group and its competitors. Polaris Group's current OCF Margin % is -9,842.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polaris Group stock overvalued right now?
Based on GuruFocus' analysis, Polaris Group (TPE:6550) is currently considered Possible Value Trap. The stock's GF Value™ is NT$55.10, compared to a current price of NT$12.50 — trading 77.3% below its estimated fair value. The current OCF Margin % is -9,842.52%. Polaris Group's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Polaris Group (TPE:6550), the current OCF Margin % is -9,842.52% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Polaris Group (TPE:6550) Overvalued in 2026?

Based on GuruFocus' analysis, Polaris Group stock appears to be undervalued. The current stock price of NT$12.50 is trading 77.3% below its estimated GF Value™ of NT$55.10. GuruFocus considers Polaris Group to be Possible Value Trap.

Key valuation signals for TPE:6550:

  • OCF Margin %: -9,842.52%
  • GF Value™: NT$55.10 vs. price of NT$12.50 (77.3% below fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the TPE:6550 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Polaris Group Business Description

Address Ugland House, PO Box 309, Grand Cayman, CYM, KY1-1104
Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.
59GF Score

Get the complete analysis for TPE:6550

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$12.50
Price
NT$55.10
GF Value